A Study of of HOT1030 in Patients With Advanced Solid Tumors

NCT05060263 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: HOT-1030

Sponsor

Huabo Biopharm Co., Ltd.